Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Peter Bult
Affiliation
Radboud University Medical Center
ORCID
Career Start Year
1994
Papers
120
H Index
36
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37999727
Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.
Eur Radiol
2024
37138190
Screening and diagnostic breast MRI: how do they impact surgical treatment? Insights from the MIPA study.
Eur Radiol
2023
37014237
US and Digital Breast Tomosynthesis in Women with Focal Breast Complaints: Results of the Breast US Trial (BUST).
Radiology
2023
37106226
The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer.
Clin Exp Metastasis
2023
34643778
Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA).
Eur Radiol
2022
36533707
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
Cancer
2022
36347887
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer.
NPJ Breast Cancer
2022
33000376
The value of mammography in women with focal breast complaints in addition to initial targeted ultrasound.
Breast Cancer Res Treat
2021
33796997
The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study.
Ann Surg Oncol
2021
33640523
Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics.
Breast
2021
34542618
Assessment of Silicone Particle Migration Among Women Undergoing Removal or Revision of Silicone Breast Implants in the Netherlands.
JAMA Netw Open
2021
34418427
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panel.
Hum Pathol
2021
34005937
Nearest-neighbor connectedness theory: A general approach to continuum percolation.
Phys Rev E
2021
33187974
Ultrastaging methods of sentinel lymph nodes in endometrial cancer - a systematic review.
Int J Gynecol Cancer
2021
31415692
Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.
Am J Clin Pathol
2020
33030998
Trends in pre-operative needle biopsy use in invasive breast cancer diagnosis: a Dutch nationwide population study.
Acta Oncol
2020
32737712
Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance.
Breast Cancer Res Treat
2020
32839548
Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion.
Nat Cell Biol
2020
32524674
Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?
Breast J
2020
32179443
Histological subtypes in triple negative breast cancer are associated with specific information on survival.
Ann Diagn Pathol
2020
32377813
Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study.
Eur Radiol
2020
32561098
Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer.
Surg Oncol
2020
32536526
Reliability of MRI tumor size measurements for minimal invasive treatment selection in small breast cancers.
Eur J Surg Oncol
2020
30652985
Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
Invest Radiol
2019
31406196
HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study.
Sci Rep
2019
31623649
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
Breast Cancer Res
2019
31340200
The molecular genetic make-up of male breast cancer.
Endocr Relat Cancer
2019
31222166
Deep learning assisted mitotic counting for breast cancer.
Lab Invest
2019
30989469
Deep learning and manual assessment show that the absolute mitotic count does not contain prognostic information in triple negative breast cancer.
Cell Oncol (Dordr)
2019
30796568
Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
Eur Radiol
2019
30972613
Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
Breast Cancer Res Treat
2019
31049740
A systematic review on the use of the breast lesion excision system in breast disease.
Insights Imaging
2019
31021414
Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls.
Histopathology
2019
30716025
From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 Challenge.
IEEE Trans Med Imaging
2019
29040037
Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Radiology
2018
29997220
Intravital microscopy of collective invasion plasticity in breast cancer.
Dis Model Mech
2018
30075794
The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Breast Cancer Res
2018
29994086
Whole-Slide Mitosis Detection in H&E Breast Histology Using PHH3 as a Reference to Train Distilled Stain-Invariant Convolutional Networks.
IEEE Trans Med Imaging
2018
29860392
1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset.
Gigascience
2018
29555332
Vulvar cancer: Two pathways with different localization and prognosis.
Gynecol Oncol
2018
29495112
Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing.
Histopathology
2018
29383629
The frequency of missed breast cancers in women participating in a high-risk MRI screening program.
Breast Cancer Res Treat
2018
29396493
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.
Nat Commun
2018
28975433
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study.
Breast Cancer Res Treat
2018
29351560
The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
PLoS One
2018
28064435
3D volume reconstruction from serial breast specimen radiographs for mapping between histology and 3D whole specimen imaging.
Med Phys
2017
28461034
Cervical metastases originating from a primary rectal adenocarcinoma due to a pagetoid spread.
Hum Pathol
2017
28325747
Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu.
J Clin Pathol
2017
28267555
Time to enhancement derived from ultrafast breast MRI as a novel parameter to discriminate benign from malignant breast lesions.
Eur J Radiol
2017
29234806
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
JAMA
2017
1 - 50 of 120
Column Actions
Search
Recommended Authors
Leen Slaets
50148Janssen Pharmaceutica NV
Career Start Year
2014
Number of shared co-authors
4
Carmen Criscitiello
University of Milano
Career Start Year
2008
Number of shared co-authors
1
Samuel Leung
University of British Columbia
Career Start Year
2007
Number of shared co-authors
3
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year
2007
Number of shared co-authors
10
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year
2005
Number of shared co-authors
6
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2004
Number of shared co-authors
0
Tanya L Hoskin
Division of Biostatistics and Clinical Trials, Mayo Clinic
Career Start Year
2003
Number of shared co-authors
3
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year
2003
Number of shared co-authors
4
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year
2002
Number of shared co-authors
3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year
2002
Number of shared co-authors
0
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year
2002
Number of shared co-authors
9
Judy C Boughey
Mayo Clinic
Career Start Year
2001
Number of shared co-authors
0
Rita A Sakr
Universite Libre de Bruxelles
Career Start Year
2000
Number of shared co-authors
5
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year
2000
Number of shared co-authors
9
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
3
Isabel T Rubio
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Career Start Year
1998
Number of shared co-authors
4
Sarah L Blair
University of California
Career Start Year
1996
Number of shared co-authors
0
Amy C Degnim
Mayo Clinic
Career Start Year
1996
Number of shared co-authors
3
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
7
Susan J Done
University Health Network
Career Start Year
1994
Number of shared co-authors
0
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year
1992
Number of shared co-authors
0
Wey L Leong
University Health Network
Career Start Year
1992
Number of shared co-authors
0
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year
1991
Number of shared co-authors
3
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year
1987
Number of shared co-authors
1
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year
1986
Number of shared co-authors
1
Bruce Youngson
University Health Network
Career Start Year
1985
Number of shared co-authors
0
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year
1985
Number of shared co-authors
0
David R McCready
University of Toronto, University Health Network
Career Start Year
1984
Number of shared co-authors
0
Sunil R Lakhani
University of Queensland
Career Start Year
1983
Number of shared co-authors
10
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year
1981
Number of shared co-authors
5
row(s) 1 - 30 of 30
Collaborators
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
20
Nico Karssemeijer
Radboud University Medical Center
Co-authored papers
17
Jeroen A W M van der Laak
Radboud University Medical Center
Co-authored papers
14
Maschenka Balkenhol
Radboud University Medical Center
Co-authored papers
12
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Co-authored papers
10
Geert Litjens
Radboud Institute for Health Sciences, Radboud University Medical Center
Co-authored papers
8
Willem Vreuls
Canisius Wilhelmina Hospital
Co-authored papers
8
Meyke Hermsen
Radboud University Medical Center
Co-authored papers
6
Babak Ehteshami Bejnordi
Radboud University Medical Center
Co-authored papers
6
Paul N Span
Radboud University Medical Center
Co-authored papers
5
Bram van Ginneken
Radboud University Medical Center
Co-authored papers
4
Quirine F Manson
Alrijne Hospital Leiderdorp
Co-authored papers
4
David Tellez
Phoenix Children's Hospital
Co-authored papers
4
Han G Brunner
Maastricht University Medical Centre
Co-authored papers
3
Oscar Geessink
Radboud University Medical Center
Co-authored papers
3
Fred C G J Sweep
Radboud University Medical Centre
Co-authored papers
3
Fiona J Gilbert
Cambridge University
Co-authored papers
3
Marcory C R F van Dijk
1Rijnstate Hospital
Co-authored papers
3
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers
3
Lambertus A Kiemeney
Co-authored papers
2
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers
2
Hao Chen
The Hong Kong University of Science and Technology
Co-authored papers
2
Huangjing Lin
The Chinese University of Hong Kong
Co-authored papers
2
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers
2
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Co-authored papers
2
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers
2
Nikolas Stathonikos
University Medical Center Utrecht
Co-authored papers
2
Aoxiao Zhong
Massachusetts General Hospital, Harvard University
Co-authored papers
2
Quanzheng Li
Massachusetts General Hospital
Co-authored papers
2
Peter Bandi
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center
Co-authored papers
2
1 - 30